KRAS and neoplasm: Gain- and loss-of-function experiments in pancreatic and colorectal cancer cell lines demonstrate that oncogenic KRAS promotes SG formation as an adaptive mechanism to a variety of tumor-associated stress stimuli (Grabocka and Bar-Sagi, 2016).